Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Tischer, Johanna  [Clear All Filters]
2020
Cesaro, S., Pillon, M., Sauer, M., Smiers, F., Faraci, M., de Heredia, C.Díaz, Wynn, R., Greil, J., Locatelli, F., Veys, P., et al. (2020). Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Tra.Bone Marrow Transplant.
2019
Radujkovic, A., Dietrich, S., Blok, H.-J., Nagler, A., Ayuk, F., Finke, J., Tischer, J., Mayer, J., Koc, Y., Sorà, F., et al. (2019). Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors - A retrospective study by the EBMT Chronic Malignancies Working Party.Biol Blood Marrow Transplant.
Bazarbachi, A.Hamid, Hamed, R.Al, Labopin, M., Afanasyev, B., Hamladji, R.-M., Beelen, D., Eder, M., Scheid, C., Wu, D., Bunjes, D., et al. (2019). Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party.Bone Marrow Transplant.
Santoro, N., Labopin, M., Ciceri, F., van Lint, M.Teresa, Nasso, D., Blaise, D., Arcese, W., Tischer, J., Bruno, B., Ehninger, G., et al. (2019). Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia over 45 years of age.Cancer.
Bazarbachi, A., Boumendil, A., Finel, H., Castagna, L., Dominietto, A., Blaise, D., Diez-Martin, J.L., Tischer, J., Gulbas, Z., Wallet, H.L., et al. (2019). Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study.Br J Haematol.
2018
Shimoni, A., Labopin, M., Lorentino, F., van Lint, M.Teresa, Koc, Y., Gulbas, Z., Tischer, J., Bruno, B., Blaise, D., Pioltelli, P., et al. (2018). Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.Leukemia.
Fraccaroli, A., Prevalsek, D., Fritsch, S., Haebe, S., Bücklein, V., Schulz, C., Hubmann, M., Stemmler, H.-J., Ledderose, G., Hausmann, A., et al. (2018). Sequential HLA-haploidentical transplantation utilizing post-transplantation cyclophosphamide for GvHD prophylaxis in high-risk and relapsed/refractory AML/MDS.Am J Hematol.
2016
Hubmann, M., Fritsch, S., Zoellner, A.-K., Prevalsek, D., Engel, N., Bücklein, V., Mumm, F., Schulz, C., Stemmler, H.Joachim, Jäger, G., et al. (2016). Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation.J Clin Virol82, 33-40.
Ruggeri, A., Battipaglia, G., Labopin, M., Ehninger, G., Beelen, D., Tischer, J., Ganser, A., Schwerdtfeger, R., Glass, B., Finke, J., et al. (2016). Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study.J Hematol Oncol9, 89.
2014
Vogt, V., Schick, J., Ansprenger, C., Braeu, M., Kroell, T., Kraemer, D., Köhne, C.-H., Hausmann, A., Buhmann, R., Tischer, J., et al. (2014). Profiles of Activation, Differentiation-Markers, or β-Integrins on T Cells Contribute to Predict T Cells' Antileukemic Responses After Stimulation With Leukemia-derived Dendritic Cells.J Immunother37, 331-347.
2013
Christopeit, M., Kuss, O., Finke, J., Bacher, U., Beelen, D.Wilhelm, Bornhäuser, M., Schwerdtfeger, R., Bethge, W.Andreas, Basara, N., Gramatzki, M., et al. (2013). Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change.J Clin Oncol.